Colistin as a first choice antibiotic for the initial empiric antimicrobial therapy of ventilator-associated pneumonia

European Respiratory Journal

Volumn 30, Issue 6, 2007, Pages 1234-1235

  Ioannides, K ^a   Myrianthefs, P ^a   Baltopoulos, G ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; COLISTIN; GENTAMICIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; DRUG CHOICE; DRUG EFFECT; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; LETTER; MORTALITY; PRIORITY JOURNAL; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; BACTERIA; COLISTIN; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED;

EID: 38849190720     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00102207     Document Type: Letter

References (4)

1. Rios FG, Luna CM, Maskin B, et al. Ventilator-associated pneumonia due to colistin susceptible-only microorganisms. Eur Respir J 2007; 30: 307-313.
2. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
3. Torres A, Ewig S. Diagnosing ventilator-associated pneumonia. N Engl J Med 2004; 350: 433-435.
4. Beardsley JR, Williamson JC, Johnson JW, Ohl CA, Karchmer TB, Bowton DL. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest 2006; 130: 787-793.